UNICYCIVE THERAPEUTICS, INC. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2026-06-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2026-03-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-09-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding | Preferred Stock, Liquidation Preference, Value | Preferred Stock Dividends and Other Adjustments | Preferred Stock, Dividend Rate, Percentage | Preferred Stock Convertible Conversion Price | Preferred Stock Convertible Shares Issuable | Preferred Stock, Dividends, Per Share, Cash Paid | Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | 10.00M shares 10-Q · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | |||||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | 10.00M shares 10-Q · filed 2026-05-12 | 0.00 shares 10-Q · filed 2026-05-12 | 0.00 shares 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | $0.00 10-Q · filed 2026-08-12 | 10.00M shares 10-Q · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | |||||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | 10.00M shares 10-Q · filed 2025-11-12 | 0.00 shares 10-Q · filed 2025-11-12 | 0.00 shares 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | 10.00M shares 10-Q · filed 2025-08-14 | |||||||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | 9.85M shares 10-Q · filed 2025-05-14 | 8.00% 10-Q · filed 2025-05-14 | $1.00 10-Q · filed 2025-05-14 | 1.00K shares 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 | 10.00M shares 10-K · filed 2026-03-30 | 0.00 shares 10-K · filed 2026-03-30 | 0.00 shares 10-K · filed 2026-03-30 | $1.09M 10-K · filed 2026-03-30 | 8.00% 10-K · filed 2025-03-31 | $1.00 10-K · filed 2025-03-31 | 1.00K shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $1.00K 10-Q · filed 2024-11-13 | $1.09M 10-Q · filed 2025-11-12 | 8.00% 10-Q · filed 2024-11-13 | $1.00 10-Q · filed 2024-11-13 | 1.00M shares 10-Q · filed 2024-11-13 | ||||||
| 2024-06-30 | $887.00K 10-Q · filed 2025-08-14 | 14.00% 10-Q · filed 2024-08-14 | |||||||||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 | 9.90M shares 10-Q · filed 2024-05-13 | $208.00K 10-Q · filed 2024-05-13 | 14.00% 10-Q · filed 2024-05-13 | |||||||
| 2023-12-31 | $0.00 10-Q · filed 2024-05-13 | 9.93M shares 10-Q · filed 2024-05-13 | $867.00K 10-K · filed 2025-03-31 | 14.00% 10-K · filed 2024-03-28 | $1000.00 10-K · filed 2024-03-28 | ||||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | 9.93M shares 10-Q · filed 2023-11-14 | 0.00 shares 10-Q · filed 2023-11-14 | 0.00 shares 10-Q · filed 2023-11-14 | $72.00K 10-Q · filed 2023-11-14 | 14.00% 10-Q · filed 2023-11-14 | $1000.00 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | 9.97M shares 10-Q · filed 2023-08-14 | $603.00K 10-Q · filed 2024-08-14 | 14.00% 10-Q · filed 2023-08-14 | $1000.00 10-Q · filed 2023-08-14 | ||||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-16 | 30.19K shares 10-Q · filed 2023-05-16 | 30.19K shares 10-Q · filed 2023-05-16 | 30.19K shares 10-Q · filed 2023-05-16 | $30.60K 10-Q · filed 2023-05-16 | $192.00K 10-Q · filed 2024-05-13 | 14.00% 10-Q · filed 2023-05-16 | $1000.00 10-Q · filed 2023-05-16 | $1000.00 10-Q · filed 2023-05-16 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 | 10.00M shares 10-K · filed 2024-03-28 | 0.00 shares 10-Q · filed 2023-11-14 | 0.00 shares 10-Q · filed 2023-11-14 | $0.00 10-Q · filed 2023-05-16 | ||||||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | 10.00M shares 10-Q · filed 2022-11-14 | |||||||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | 10.00M shares 10-Q · filed 2022-08-15 | |||||||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | 10.00M shares 10-Q · filed 2022-05-12 | |||||||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | 10.00M shares 10-K · filed 2023-03-31 | |||||||||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 | 10.00M shares 10-Q · filed 2021-11-12 | 0.00 shares 10-Q · filed 2021-11-12 | 0.00 shares 10-Q · filed 2021-11-12 | |||||||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | 10.00M shares 10-Q · filed 2021-08-16 | 0.00 shares 10-Q · filed 2021-08-16 | 0.00 shares 10-Q · filed 2021-08-16 | |||||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 | 10.00M shares 10-K · filed 2022-03-31 | 0.00 shares 10-Q · filed 2021-11-12 | 0.00 shares 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |